Header cover image

South Korean (KOSPI) Pharma Industry Analysis

UpdatedApr 19, 2024
DataAggregated Company Financials
Companies98
  • 7D-1.0%
  • 3M-0.4%
  • 1Y4.5%
  • YTD-10.1%

Over the last 7 days, the Pharma industry has dropped 5.0%, driven by SK Biopharmaceuticals declining 8.7%. In contrast, Oscotec has gained 6.9%. As for the longer term, the industry's performance has been flat for the past year. As for the next few years, earnings are expected to grow by 34% per annum.

Industry Valuation and Performance

Has the South Korean Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 19 Apr 2024₩50.5t₩29.4t₩922.9b16.5x54.7x1.7x
Sun, 17 Mar 2024₩53.2t₩29.7t₩728.2b20.5x73.1x1.8x
Tue, 13 Feb 2024₩50.8t₩29.6t₩593.1b21.3x85.6x1.7x
Thu, 11 Jan 2024₩54.4t₩29.6t₩588.5b23.7x92.4x1.8x
Sat, 09 Dec 2023₩50.7t₩29.6t₩590.4b22x85.9x1.7x
Mon, 06 Nov 2023₩46.5t₩29.3t₩683.3b15.8x68.1x1.6x
Wed, 04 Oct 2023₩50.9t₩29.3t₩683.3b17.1x74.5x1.7x
Fri, 01 Sep 2023₩51.2t₩29.3t₩677.3b16.6x75.6x1.7x
Sun, 30 Jul 2023₩48.9t₩28.8t₩884.1b21.7x55.3x1.7x
Tue, 27 Jun 2023₩47.9t₩28.9t₩908.3b20.9x52.8x1.7x
Thu, 25 May 2023₩48.5t₩28.7t₩878.4b22.3x55.2x1.7x
Sat, 22 Apr 2023₩47.9t₩28.5t₩602.7b21x79.5x1.7x
Mon, 20 Mar 2023₩44.8t₩27.8t₩637.1b19.6x70.3x1.6x
Wed, 15 Feb 2023₩45.2t₩27.7t₩743.5b20.3x60.8x1.6x
Fri, 13 Jan 2023₩45.6t₩28.0t₩770.2b19.9x59.2x1.6x
Sun, 11 Dec 2022₩46.4t₩28.0t₩770.4b19.1x60.2x1.7x
Tue, 08 Nov 2022₩42.9t₩27.2t₩694.8b20.5x61.7x1.6x
Thu, 06 Oct 2022₩41.7t₩27.2t₩694.8b20.2x60.1x1.5x
Sat, 03 Sep 2022₩48.2t₩27.5t₩725.5b22.9x66.4x1.8x
Mon, 01 Aug 2022₩51.3t₩26.7t₩475.9b23.4x107.7x1.9x
Wed, 29 Jun 2022₩47.5t₩26.7t₩475.9b20.7x99.7x1.8x
Fri, 27 May 2022₩53.5t₩26.3t₩599.8b24.8x89.2x2x
Sun, 24 Apr 2022₩56.4t₩26.1t₩674.3b26.7x83.6x2.2x
Tue, 22 Mar 2022₩56.2t₩25.4t₩986.9b24x57x2.2x
Thu, 17 Feb 2022₩52.6t₩25.0t₩934.5b22.4x56.3x2.1x
Sat, 15 Jan 2022₩57.1t₩25.0t₩934.5b24.5x61.1x2.3x
Mon, 13 Dec 2021₩61.4t₩25.0t₩933.1b26x65.8x2.5x
Wed, 10 Nov 2021₩60.0t₩24.7t₩875.4b23.8x68.6x2.4x
Fri, 08 Oct 2021₩62.2t₩24.7t₩876.1b23.6x71x2.5x
Sun, 05 Sep 2021₩74.3t₩26.0t₩960.3b40x77.4x2.9x
Tue, 03 Aug 2021₩70.3t₩25.3t₩928.3b40.7x75.7x2.8x
Fri, 07 May 2021₩69.3t₩24.9t₩915.5b34.8x75.7x2.8x
Price to Earnings Ratio

75.7x


Total Market Cap: ₩69.3tTotal Earnings: ₩915.5bTotal Revenue: ₩24.9tTotal Market Cap vs Earnings and Revenue0%0%0%
South Korean Pharma Industry Price to Earnings3Y Average 72.7x202220232024
Current Industry PE
  • Investors are pessimistic on the South Korean Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 53.3x which is lower than its 3-year average PE of 72.7x.
  • The 3-year average PS ratio of 2.0x is higher than the industry's current PS ratio of 1.7x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have remained mostly flat over the last three years.
  • Meanwhile revenues for these companies have grown 5.6% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.

Industry Trends

Which industries have driven the changes within the South Korean Healthcare industry?

KR Market-2.38%
Healthcare-0.18%
Pharma-1.04%
Pharma-1.04%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
A195940 HK inno.N₩36.50k3.8%
+₩38.2b
12.0%n/a
A053030 BINEX₩14.69k8.0%
+₩33.7b
56.4%PE97.3x
A003220 Daewon Pharmaceutical₩15.37k8.2%
+₩24.8b
5.3%PE13.6x
A006620 DongKoo Bio & Pharma₩6.85k9.6%
+₩16.6b
10.3%PE16x
A039200 Oscotec₩28.75k1.4%
+₩15.3b
28.6%PS221.8x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

A000100

₩69,400.00

Yuhan

7D

-2.5%

1Y

29.4%

A195940

₩36,500.00

HK inno.N

7D

3.8%

1Y

12.0%

A200670

₩33,500.00

Humedix

7D

2.0%

1Y

24.5%

A128940

₩308,000.00

Hanmi Pharm

7D

-2.5%

1Y

0.7%

A008930

₩32,050.00

Hanmi Science

7D

-8.4%

1Y

-26.3%

A039200

₩28,750.00

Oscotec

7D

1.4%

1Y

28.6%

A086450

₩16,280.00

DongKook Pharmaceutical

7D

1.1%

1Y

7.0%

A067080

₩10,200.00

DAE HWA Pharmaceutical

7D

3.7%

1Y

7.4%

A069620

₩108,400.00

Daewoong Pharmaceutical

7D

-5.5%

1Y

0.5%